Alexis Gilroy, a national leader in the digital health industry, advises on complex transactional and health regulatory issues with an emphasis on virtual health methods, such as telemedicine, telehealth, and mobile health. Alexis is co-leader of the Firm’s Health Care & Life Sciences Practice.
Focused on transactions in the health care, life sciences, and digital health sectors for almost two decades, Alexis pairs practical experience with a keen understanding of often novel federal and state regulatory requirements. Health systems and other health providers, virtual care companies, technology organizations, pharmacy and retail leaders, life sciences businesses, medical device organizations, and investors across the United States and abroad seek her legal counsel on various digital health topics. She frequently structures and negotiates telehealth specific services and affiliation contracts and manages health regulatory matters for M&A and equity transactions with both investor/buy-side and company/target-side experience. She also advises on multijurisdictional digital health strategy and implementation, state-specific telehealth regulation, corporate practice of medicine, reimbursement, online prescribing, patient consent, credentialing by proxy, remote supervision, and fraud and abuse considerations.